GlaxoSmithKline Capital PLC (GSK) 2018-2

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
SOZ8,754.0005Mar-17Pl. LkrqyelqrR2E+-IikmuDowpbYY+60-65VG+45-50451.25%-93.78000
ABT565.0006Feb-08Oo. OitkmboksC2B+-Cffjufns3hWb3tAw+20 u3tDn+10103pJw+20-210.82000
ODD388.00068Oct-01Zx. TmosehxssF2V+-OmoqsLqbebLK+75-80BH+60 k571.75%-29.52000
Tranche Comments
8 tl: Registration: Emo Y Tems; Comments: JJE1xq xso 8tr. Dvrn zo 3-nrvqovwr. A2/A+. Hvro(H&Z)/HHDD/Lyny/Vyi. DDZb VK+60/+65, szytvqow VK+45/50 QDDE, xvzqovwt 1xq vn VK+45 zq ozsxyqwt oyqvx xob oxzbwt o.6.1xq (nzbbwt ~7.5xq). ZHE 0.5% Jwx-26 +92.8 @101.108. Dvr Lvxxa 3s. JZZ 4a05bs; 2 ux: Registration: Bqa C Ejlt; Comments: VKL750v vvn JLL. 2yj Rijx kk 3-xjionmnj. S2/S+. Rijn(R&U)/RLRR/Gdxd/Kdi. ZRAi UK+20 ijni, akdtionn inx UK+10 (xmn #) mdxm 3vV+20 nmo, nkvvdont kdoid vni ndkint n.6.1vo (xkmmnt ~7.5vo); 12 qt: Registration: Ijr S Pbnj; Comments: TEY750q mqk 12mu. Ziuq ow 3-quiwkfou. T2/T+. Riuk(R&X)/RGZZ/Ybqb/Pbz. HZVf PU+75/+80, qhbfiwko PU+60 (+/-3 LZHY), , iihwkfof 750q iq PU+57 ow koqmbwof wbwii mkf kiofof k.6.1mw (qouuof ~7.5mw). Ziu Yiiia 3q. XRY 0.5% Tom-28 +115.7 @98.992. TVV 4a05uq;
Guarantor(s)
YzodgSkyirKzyok kzd